Delivery Order SPE2DB22D2211-SPE2DB25FSBFK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, with a ceiling value of $20,404.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,620.90 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on August 12, 2025, with completion expected by August 13, 2025. This is a firm fixed-price, non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.51 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, with no set-aside designation applied. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for OPZELURA 1.5% Cream (60GM), a topical pharmaceutical product. This firm fixed price delivery order, valued at $6,096.29, is scheduled for completion by July 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award utilized competitive procedures with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $3,199.78 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM), a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 23, 2025. The award represents a discrete transaction under AmerisourceBergen's broader contracting relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram unit on September 4, 2025, with a ceiling value of $2,171.95. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order represents a child...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBFKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,673.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders across therapeutic domains demonstrates its capability to meet federal procurement requirements and support DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/21/25 |